Income statement revenue $1.71B (+29.6% YoY).Operating income $325.05M (+269.9% YoY).Pre-tax result $312.46M (+213.9% YoY).Net result $237.01M (+151.3% YoY).

BLINCYTO: $36.54M (+42.8% YoY)
BRUKINSA: $1.25B (+31.4% YoY)
KYPROLIS: $15.15M (-22.0% YoY)
Other: $37.82M (+78.8% YoY)
Other Revenue: $25.28M (+91.1% YoY)
POBEVCY: $9.63M (-14.3% YoY)
TEVIMBRA: $228.52M (+18.1% YoY)
XGEVA: $104.5M (+28.5% YoY)
Research and development: $612.28M (+16.6% YoY)
Selling, general and administrative: $593.21M (+10.3% YoY)
Other expense: $12.59M
Income tax expense: $75.45M (+1343.0% YoY)

Loading financials

Income statement income statement flow. Revenue $1.71B. Net result $237.01M.

Income statement revenue $1.71B (+29.6% YoY).Operating income $325.05M (+269.9% YoY).Pre-tax result $312.46M (+213.9% YoY).Net result $237.01M (+151.3% YoY).

BLINCYTO: $36.54M (+42.8% YoY)
BRUKINSA: $1.25B (+31.4% YoY)
KYPROLIS: $15.15M (-22.0% YoY)
Other: $37.82M (+78.8% YoY)
Other Revenue: $25.28M (+91.1% YoY)
POBEVCY: $9.63M (-14.3% YoY)
TEVIMBRA: $228.52M (+18.1% YoY)
XGEVA: $104.5M (+28.5% YoY)
Research and development: $612.28M (+16.6% YoY)
Selling, general and administrative: $593.21M (+10.3% YoY)
Other expense: $12.59M
Income tax expense: $75.45M (+1343.0% YoY)